BerGenBio $BGBIO.OL rallies amid Norwegian biotech optimismBerGenBio OSL:BGBIO is a norwegian clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential cornerstone of therapy for aggressive diseases, including immune-evasive, therapy resistant cancers.
The stock is currently in a short term uptrend that could provide a new test of important resistance, where a breakout to the upside could trigger a powerful buy signal.
Sponsored analyst summary:
www.trinitydelta.org
Twitter:
twitter.com
Investor Relations:
www.bergenbio.com
Telenor nearing buy zone Telenor is currently in a bearish trend, but it's nearing the area where one should look to buy.
We have two significant horisontal supports. The first @ 156.75, and the second at 150.45.
The logic game plan for me, is to place equal bids at the two levels. Making the potential average cost 153.6.
TP 1: 180
(TP 2: 190)
breaking out of pattern?NAS can get compensation from Boeing in 2019, will the stock break out of it falling pattern?
Kongsberg Gruppen trend change, entry 136.1 We've had some positive price development lately, and it looks like the trend is turning bullish.
Golden cross MA50 above MA200 of course adds to our case.
Current resistance is at 142.5....Interested in an entry @ 136.1 marked by the yellow line.
ENTRA en route to price discovery. Blackrock on board Entra hitting new all time highs, here's a possible way to ride the trend at a 6% risk, setting stops below the wick at the last weekly candle.
Blackrock purchased stocks in Entra worth roughly $11m last week.
Aker Solutions.. High risk high reward This consolidation will eventually end, and take a direction.
The obvious play here is to buy here at the lower end of the consolidation. If this breaks out to the upside it can provide solid returns.
Yara bet x 338As we can see from the 1hr here, price bounced off support at 338 at decent volume. This indicates a switch in momentum to the north.
I see resistance at 370 as the target price. But be aware that 200MA will probably provide some resistance first, since it has been well respected in this downtrend.
NB: Entry, SL & TP is calculated from 338, price is now trading at 446.xx
Twin peaks or blue book dream?Any thoughts on this scenario? would P1 and P2 qualify as double peak (supposedly a bullish formation), and is it in your opinion consistent with the later emerging upward trend (double channel)?
As I understand it, a prerequisite for a bullish development is the high traded volume at Peak2 (bottom).
Any opinions and contributions much appreciated!
Possible horizontal development Another attempt to identify the development for the stock in which I hold my largest position. This multi disciplinary "national treasure" company, with very long lines back to the original Fred. Olsen-company, is ideal for me to practice on. It´s stable development trends is very forgiving for the rookie eye to experiment with.
Now, a possible horizontal movement could be under development after a long and steady climb. I will make an attempt at possible future developments based on this preschool sketch later :)
Possible vertical developmentAs an amateur I am using this long traditions "national treasure" multi disciplinary company as an easily accessible stock for practicing eye on patterns. I hold my largest position in this stock. It is traditionally stable, with relatively clear patterns. Now, a possible horizontal trend under development after a long and steady climb. Tradingview´s barometer is still in the buy.
So once again, a pre-school sketch attempt from me :)
NEL still holds its 110 % per year rising channelNEL is definitely in the buying zone here at 7.5 NOK where a tight stop loss as indicated by the black line can result in 9 % loss. But on the upside it can continue its trend with 110 % gain per year. Disclaimer, I bought stocks in NEL at 7.35 NOK
My first scetch drawing and publishing attempt :DThis is not really an analysis (obviously), I just wanted to test the functions and see if the emerging pattern makes any sense.
Scandinavian Airlines OB Trade SAS dropped a lot today due to Q3 presentation.
Looking at a retest of the Order Block @13.10 for a potential entry.
NEL suggested route All the indicators has the same conclusion, bears are taking over. Weak momentum and no clear direction, could be a flammable combination for the Norweigan hydrogen company.
Three Drives, yay or nay?For the three drive pattern to be validated the second leg down should touch the trendline and the time intervalls between the ups and downs should be close to identical. Due to recent noise which always seems to be around NAS and the last stock issue (again) it’s hard to predict the next impulse up. But then again, this does not look too far from a classic three drives pattern.
Happy trading!
NEL ASA (Part of my hydrogen portfolio)Definitely a long term investment for every portfolio size.
Fundamental:
The Company delivers solutions to produce, store and distribute hydrogen from renewable energy. Nel ASA serves industries, energy and gas companies with hydrogen technology. The Company’s hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing fuel cell electric vehicles with the same fueling and long range as conventional vehicles.
They working on a new processing technology which will reduce the manufacturing costs drastically.
It is just a matter of time that big car companies will produce hydrogen vehicles in mass. NEL ASA provides the hydrogen technique.
Financial Q3 showed a revenue rise.
__________________
Technical:
Upward trend.
Bollinger Band: Long
Sochastic RSI: Long
Moving Average(100):Long
Targovax $TRVX.OL clinical phase oncolytic virus valued 35 mUSDTargovax OSL:TRVX a clinical phase norwegian Biotech is currently at market cap NOK 327 million / 35 million USD.
Value inflection point very close as the company will need to raise funds in the very near future, which must either come from investors or from a possible partner deal.
PRESENTATION OF ONCOS-102 MELANOMA DATA AT SITC ANNUAL MEETING
www.healthcap.eu
Q3 report:
www.targovax.com
Q3 transcript:
finance.yahoo.com
Crayon - time to secure profits ?Trendline shown here functioned first as support, then as resistance for the last 6.5 months since beginning of april. By failing to move above it at the second attempt nov 20th, I would expect the stock to enter into a new trend. That trend can be down, sideways, or up at a slower rate than it has been going so far. Time to secure profits, and wait for a new signal ?
KIT - long, 6 month hold. A solid norwegian profitable growth company with dividend payouts. Mostly sideways, expect breakout on Q4 2019 i feb or Q1 2020 in may when they release 2020 guidance. Target: 12kr, +25% from november to may is the bet.
